Sesame Summit 2026 – application open

Best HealthTech Events

Not seeing your favorite HealthTech event here? smrs/link.add-event

Upcoming HealthTech events

The Festival of Biologics 2023

Mar 20-22 – USA
The Festival of Biologics brings together pharma & biotech, academics, and research institutes, together with their partners across the value chain. Across antibodies, immunotherapy, and biosimilars our participants share research, create new partnerships, and tackle the clinical trials, manufacturing, and commercial challenges involved in bringing new therapies to market.

ViVE 2023

Mar 26-29 – USA
ViVE provides a fresh, curated education and networking experience for digital health leaders, disruptors and influencers. They’re bringing together C-suite executives, senior digital health leaders and buyers, health startups and investors, and government and solution providers to advance healthcare.

Reuters Events: Pharma 2023

Apr 18-20 – Spain
Join 100s of your peers at one of the world’s gatherings for pharma pioneers and health innovators. One of the biggest, most senior, and cross-functional commercial pharma events.

LSX World Congress 2023

May 3-4 – UK
The 9th LSX World Congress is the leading partnering, strategy and investment event in Europe, with qualified 1:1 partnering at its core. The event brings together the CEOs and senior decision makers from the world’s most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments – all geared at putting capital and ideas to work to help create the world’s future medicines and improve patient outcomes.

Future Health Summit 2023

May 24-25 – Ireland
This internationally distinguished event is an Irish and International gathering of the brightest minds in the healthcare industry with an illustrious audience of over 500 high end (C-Suite) industry delegates attending. Featuring renowned speakers from Ireland, USA, UK, Europe, and further afar.

DHIS 2023

Jun 7 – USA
The Digital Healthcare Innovation Summit (DHIS) is an unparalleled annual gathering of the leading innovators, investors, payers, providers, and policymakers who are driving the digital health revolution.

HIMSS 2023

Jun 7-9 – Portugal
HIMSS23 in Lisbon is one of the most influential health information and technology conferences and exhibitions in Europe – where healthcare leaders meet to build relationships during lively networking events, learn from experts in hot topic education sessions and discover innovative health tech products to solve their greatest challenges.

World Medical Innovation Forum 2023

Jun 12-14 – USA
How will gene and cell therapy change health care? Join CEOs, industry leaders, and Harvard’s top medical faculty to assess the future of medicine and the specific actions needed to realize the promise of emerging research for patients everywhere.

Bits & Pretzels HealthTech 2023

Jun 20-21 – Germany
Get ready to unite with the greatest minds in HealthTech! From Pharma and Tech Giants, to MedTech professionals and Policymakers- Bits & Pretzels HealthTech is bringing them all together. With startup founders at its heart, it’s an opportunity like no other for insightful collaboration with a positive ripple effect on European healthcare.

DxPx US 2023

Jul 25-27 – USA
With the gaining importance of diagnostics, digital health, precision medicine, and life science tools, there‘s a need for a dedicated platform to bring together the relevant stakeholders and further drive our industries.

Intelligent Health 2023

Sept 13-14 – Switzerland
Intelligent health will bring together the global AI and health communities to advance discussions on how to apply AI and drive technological collaboration in healthcare.

HETT 2023

Sept 26-27 – UK
HETT 2023 will explore the systems and infrastructure that underpin and enable a data-driven NHS, supporting the ecosystem to deliver patient outcomes through the meaningful implementation of technology.

The MedTech Conference 2023

Oct 9-11 – USA
Featuring world-class plenary speakers, cross-cutting educational programming, valuable networking, and business development opportunities, The MedTech Conference is a must-attend event for the industry’s prominent and most promising companies.

Reuters Events: Total Health 2023

Nov 7-8 – USA
Healthcare is still in crisis. Lessons learned during the pandemic – urgency, collaboration, speed of innovation – must now be applied to build a better healthcare system. As the world looks to the healthcare industry for guidance, Total Health is where its leaders come to set the agenda and change lives.

Frontiers Health 2023

Nov 8-9 – Italy
Frontiers Health emerged as one of the premier global digital health innovation events, with a strong focus on digital therapies, breakthrough technologies, healthcare transformation, investments, and ecosystem development.

MEDICA 2023

Nov 13-16 – Germany
Discover the full range of solutions for medical practices, clinics, and hospitals, and showcase your own. Given the focus on current as well as upcoming challenges, these are more indispensable than ever. Personal protective equipment, hygiene supplies, disposables, and much more.

GIANT Health London 2023

Nov 23-24 – UK
The GIANT (Global Innovation and New Technology) Health Event is one of the UK’s leading, unmissable healthcare innovation festival; with 4 “shows within the festival”. Come meet, network, learn, and do business with 100s of world-class speakers, immersive innovation presentations, the UK’s leading health-tech startups pitching to investors show, and more.


Past Events

CES 2023

Jan 5-8 – USA
CES one of the world’s most influential technology events will return to Las Vegas, Nevada giving the global audience access to major brands and startups, as well as the industry’s most influential leaders and advocates.

IMSH 2023

Jan 21-25 – USA
The International Meeting on Simulation in Healthcare (IMSH) is a scientific conference that explores the latest innovations and best practices in healthcare simulation. IMSH provides the tools and resources healthcare professionals need to advance their skills, impact change in delivery systems and practice, and, ultimately, improve patient safety.

you might also like

Fundraising 22 hours ago

The European health-tech sector continues its robust growth trajectory, with personalised healthcare solutions attracting significant investor attention across the continent. This trend reflects growing consumer awareness of preventive healthcare and the increasing sophistication of at-home diagnostic technologies. Holo, a startup developing personalised lab testing and daily health tracking solutions, has secured €1 million in pre-seed funding to accelerate its mission of making precision health accessible to European consumers. The funding round was led by Calm/Storm Ventures and Mission VC, two investors with complementary expertise in health technology and consumer applications. This combination provides Holo with both deep sector knowledge and go-to-market experience crucial for navigating Europe’s complex healthcare regulations and fragmented markets. Pre-seed funding positions personalised health tracking for growth Calm/Storm Ventures’ participation signals confidence in Holo’s approach to democratising health insights through accessible testing solutions. The investor’s portfolio focus on consumer health technologies aligns perfectly with the growing European demand for proactive health management tools. Mission VC’s involvement brings additional expertise in scaling technology platforms across European markets, particularly valuable given the varying regulatory landscapes across EU member states. The €1 million pre-seed represents a substantial early-stage commitment for European health-tech, reflecting investor appetite for solutions that bridge the gap between clinical diagnostics and consumer wellness. Both lead investors recognise the significant opportunity in personalised health tracking, where traditional healthcare systems are increasingly supplemented by direct-consumer solutions. “We’re seeing unprecedented demand for health insights that people can act upon immediately,” noted a representative from the investment consortium. “Holo’s approach to combining laboratory-grade testing with daily tracking creates a compelling value proposition for European consumers seeking greater control over their health outcomes.” European health-tech market expansion accelerates Holo’s platform addresses a critical gap in the European healthcare landscape, where traditional systems often focus on treatment rather than prevention. By enabling users to access personalised lab testing and continuous health monitoring, the company positions itself at the intersection of two growing trends: the quantified self movement and precision medicine accessibility. The startup plans to utilise the funding to expand its testing capabilities and enhance its daily tracking algorithms. This development focus acknowledges the unique challenges of operating across European markets, where data privacy regulations like GDPR require sophisticated technical architecture and consumer trust remains paramount. Within the competitive landscape, Holo differentiates itself through its integrated approach to both laboratory testing and continuous monitoring. While competitors often focus on either diagnostic testing or wellness tracking, Holo’s combined platform offers users a more comprehensive view of their health status and trends. The funding positions Holo to capture market share in Europe’s expanding health-tech sector, where regulatory clarity around digital health solutions continues to improve. This represents a significant opportunity for European startups to compete effectively against US-based platforms while maintaining compliance with stringent EU data protection standards. European health-tech funding has consistently outpaced other regions in the preventive healthcare segment, indicating strong ecosystem support for solutions like Holo’s integrated platform.

Fundraising 24 hours ago

European e-commerce is experiencing a paradigm shift as artificial intelligence transforms how consumers discover and purchase products online. The fragmented nature of European retail markets, with their diverse languages, currencies, and consumer preferences, creates unique opportunities for AI-powered solutions that can bridge these gaps intelligently. Paris-based Dialog has secured €3.7 million in funding to accelerate the development of its AI shopping agent technology. The round was led by Galion.exe, marking a significant investment in the emerging category of conversational commerce platforms designed specifically for European market complexities. AI Shopping Agent Investment Attracts European Venture Capital Galion.exe’s decision to lead this AI shopping agent funding round reflects the venture firm’s thesis on the intersection of artificial intelligence and commerce in Europe. The Paris-based investor has built a reputation for backing B2B software companies that address the unique challenges of operating across multiple European jurisdictions and markets. Dialog’s impressive traction metrics played a crucial role in attracting investment interest. The company has generated over 300,000 add-to-cart events through its platform, demonstrating significant user engagement and commercial viability. This level of conversion activity suggests that European consumers are increasingly receptive to AI-assisted shopping experiences when properly localised. “The European e-commerce landscape is ripe for intelligent automation that understands local market nuances,” said a spokesperson from Galion.exe. “Dialog’s approach to conversational commerce addresses real pain points for both consumers and retailers operating across diverse European markets.” Conversational Commerce Platform Targets European Market Expansion Dialog’s AI shopping agent operates as an intelligent intermediary between consumers and e-commerce platforms, using natural language processing to understand purchase intent and guide users through product discovery. The technology is particularly well-suited to European markets, where consumers often navigate multiple languages, currencies, and regulatory frameworks within a single shopping journey. The €3.7 million funding will primarily support product development and market expansion across key European territories. Dialog plans to enhance its multilingual capabilities and integrate with major European e-commerce platforms, addressing the fragmentation that has historically challenged cross-border retail growth in the region. Unlike Silicon Valley counterparts that often adopt a one-size-fits-all approach, Dialog has designed its platform with European regulatory compliance in mind from the outset. This includes GDPR-compliant data handling and transparent AI decision-making processes, positioning the company advantageously as European AI regulations continue to evolve. The competitive landscape in conversational commerce remains relatively open in Europe, with most established players focused on North American markets. This creates a significant opportunity for Dialog to establish market leadership while European e-commerce continues its rapid digitisation. Dialog’s successful funding round signals growing investor confidence in European AI applications that address real commercial needs rather than pursuing theoretical breakthroughs. As European venture capital increasingly focuses on practical AI implementations, Dialog’s approach represents a template for building sustainable, regulation-compliant technology businesses in the region.

event management funding
Fundraising 1 day ago

Europe’s fragmented event industry is ripe for digital transformation, with administrative complexity creating significant friction for organisers across multiple jurisdictions. Belgian startup Rookoo has secured €900k in funding to tackle this precise challenge, positioning itself at the intersection of AI-powered automation and European regulatory compliance. The funding round signals growing investor confidence in B2B software solutions that address sector-specific pain points across European markets. Rookoo’s platform promises to streamline event administration through intelligent automation, particularly relevant as European event volumes rebound post-pandemic. Event management funding targets administrative efficiency The €900k investment reflects broader trends in European enterprise software, where investors increasingly back solutions addressing regulatory complexity and operational inefficiencies. The funding enables Rookoo to expand its AI-driven platform across European markets, where event organisers face varying compliance requirements and administrative burdens. Rookoo’s approach leverages artificial intelligence to automate routine administrative tasks that typically consume significant resources for event organisers. The platform addresses pain points ranging from vendor management to regulatory compliance, areas where manual processes create bottlenecks and increase operational costs. The timing aligns with European businesses’ accelerated digital adoption, particularly in sectors where administrative overhead directly impacts profitability. Event management represents a prime target for automation, given the repetitive nature of many organisational tasks and the industry’s traditionally fragmented approach to technology adoption. Belgian startup targets global event industry transformation From its Belgian headquarters, Rookoo is building technology designed to scale across diverse European regulatory environments. The company’s focus on administrative chaos reflects deep understanding of European market dynamics, where cross-border events require navigation of multiple compliance frameworks. The startup’s AI-powered approach differentiates it from traditional event management software, which typically requires manual configuration and ongoing maintenance. Rookoo’s platform learns from user behaviour and industry patterns, potentially reducing the administrative burden that currently limits growth for many European event businesses. Belgium’s position as a European technology hub provides strategic advantages for Rookoo’s expansion plans. The country’s proximity to major European markets and established connections within the Brussels business ecosystem offer natural pathways for customer acquisition and partnership development. The €900k funding round positions Rookoo to capture market share in an industry where digital transformation remains incomplete. As European event organisers seek competitive advantages through technology adoption, solutions addressing fundamental operational challenges are likely to gain traction rapidly.

Subscribe to
our Newsletter!

Stay at the forefront with our curated guide to the best upcoming Tech events.